Once only the domain of plastic surgery, full or double chins can now be successfully treated with non-invasive options such as injectables and skin tightening technology.
One of the most exciting aesthetic developments for 2016 will be BELKYRA™, an injectable drug for fullness under the chin. This treatment was approved in 2015 by Health Canada and the FDA (under the label “KYBELLA”), and has been embraced by the aesthetics community.
Leaders in Double Chin Treatment
Pacific Dermaesthetics will be one of the first centers in Canada to offer this double chin treatment, and one of three clinics in Vancouver and BC. In fact, our Dermatologist Dr. Jason Rivers was one of only seven specialists from across Canada that were invited for advanced training in Toronto on the BELKYRA procedure.
As a highly experienced injector and educator, Dr. Rivers will also be training select physicians on this rare non-invasive procedure in BC.
Double Chins: Why Do They Occur?
A double chin consists of “submental adipose tissue” (fat), a very common condition that can be connected to genetics, aging and/or weight gain. However, double chins can be persistent and difficult to lose despite weight loss and lifestyle changes.
BELKYRA injections have the ability to redefine the jawline by reducing, and potentially eliminating, submental fat – without resorting to surgery.